MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • MDS Virtual Congress 2020

    Automated pattern based classification in neuropathology proven parkinsonism

    K. Schindlbeck, D. Gupta, C. Tang, S. O'Shea, K. Poston, V. Dhawan, J.P Vonsattel, S. Fahn, D. Eidelberg (New York, NY, USA)

    Objective: In patients with parkinsonism and uncertain differential diagnosis, an automated image-based algorithm can help to distinguish idiopathic Parkinson’s disease (IPD) from atypical parkinsonian syndromes…
  • MDS Virtual Congress 2020

    Brain 5-HT1 receptor binding in multiple system atrophy: A [18F]-MPPF PET study

    M. Meyer, I. Sibon, F. Lamarre, J. Asselineau, A. Foubert-Samier, J. Mazère, A. Delamarre, O. Rascol, A. Pavy-Le Traon, F. Tison, P. Fernandez, W. Meissner (Bordeaux, France)

    Objective: The primary objective was to compare brain 5-HT1a receptor binding between patients with multiple system atrophy (MSA) and healthy controls (HC). The secondary objectives…
  • MDS Virtual Congress 2020

    The usefulness of a dual-phase 18-F-FP-CIT PET in a case of Alzheimer’s disease with slow movement

    WW. Lee (Seoul, Republic of Korea)

    Objective: To think about the usefulness of a dual-phase 18-F-FP-CIT PET in cases of dementia with bradykinesia. Background: A classic 18-F-FP-CIT PET is useful in…
  • MDS Virtual Congress 2020

    Distinct compensatory and maladaptive wiring patterns in genotypic Parkinson’s disease

    K. Schindlbeck, A. Vo, N. Nguyen, A. Rommal, C. Tang, M. Niethammer, V. Dhawan, R. Saunders-Pullman, S. Bressman, D. Eidelberg (New York, NY, USA)

    Objective: Although disease networks have been identified in Parkinson’s disease (PD) using functional imaging, it is unclear whether these represent maladaptive or compensatory responses to…
  • MDS Virtual Congress 2020

    Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy

    C. Shen, F.T Liu, JJ. Ge, P. Wu, C.T Zuo, J. Wang (Shanghai, China)

    Objective: This study aimed to characterize the cognitive profiles of multiple system atrophy (MSA) and explore the possible mechanisms involved using 18F-fluorodeoxyglucose (FDG) Positron Emission…
  • MDS Virtual Congress 2020

    Abnormal pattern of brain glucose metabolism in multiple system atrophy

    G. Martí-Andrés, M. Perovnik, E. Rebec, P. Tomše, E. Prieto, T. Rus, L. Armengou-García, L. Ležaić, M. Riverol, R. Valentí, M.R Luquin, M. Trošt, J. Arbizu (Pamplona, Spain)

    Objective: To define and cross-validate the brain glucose metabolic abnormalities in patients with a clinical diagnosis of Multiple System Atrophy (MSA). Background: Despite the availability…
  • MDS Virtual Congress 2020

    FDG PET and MIBG scintigraphy in the differential diagnosis of parkinsonism: a head-to-head comparison

    N. Schröter, J. Brumberg, G. Blazhenets, L. Frings, J. Volkmann, C. Lapa, W. Jost, I. Isaias, P. Meyer (Freiburg, Germany)

    Objective: To compare the performance of [18F]fluorodeoxyglucose (FDG) PET and [123I]metaiodobenzylguanidine (MIBG) scintigraphy in the differential diagnosis of parkinsonism in the same patient sample. Background:…
  • MDS Virtual Congress 2020

    18kDa Translocator Protein PET in 4-Repeat Tauopathies – A Cross-Sectional Single Center Study

    C. Palleis, J. Sauerbeck, L. Beyer, S. Harris, J. Schmitt, A. Finze, A. Nitschmann, G. Biechele, K. Boetzel, A. Danek, B. Rauchmann, M. Unterrainer, N. Albert, R. Rupprecht, P. Bartenstein, R. Perneczky, C. Haass, J. Levin, G. Hoeglinger, M. Brendel (Munich, Germany)

    Objective: The aim of this single center study was to analyse the potential of 18F-GE-180 TSPO PET as a biomarker in 4R-tauopathies. Background: The pathological…
  • MDS Virtual Congress 2020

    Progressive supranuclear palsy: Common metabolic pattern in different variants

    G. Martí-Andrés, L. Van Bommel, S. Meles, M. Riverol, R. Valentí, R.V Kogan, R.J Renken, V. Gurvits, T. Van Laar, M. Pagani, E. Prieto, M.R Luquin, K.L Leenders, J. Arbizu (Pamplona, Spain)

    Objective: To define and cross-validate the brain glucose metabolic abnormalities in patients with a diagnosis of different PSP variants. Background: It remains unclear whether the supportive…
  • MDS Virtual Congress 2020

    Identifying neural signatures of Parkinson’s disease that predict decline in gait and postural control

    H. Sigurdsson, A. Yarnall, B. Galna, S. Lord, L. Alcock, R. Morris, R. Lawson, S. Colloby, M. Firbank, N. Pavese, D. Brooks, J. O'brien, D. Burn, L. Rochester (Newcastle upon Tyne, United Kingdom)

    Objective: To identify Parkinson’s disease [PD] specific patterns in the brain using a multi-modal neuroimaging design and use these to predict gait decline. Background: Gait…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 40
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley